In this joint webinar from Evotec and Seer, "Deep Proteomic Insight Across Human Biofluids", Evotec's Group Leader in Clinical Proteomics and Mass Spectrometry, Carleen Kluger, Ph.D. and Seer's Vice President, Proteomics, Daniel Hornburg, Ph.D. discuss a novel approach for deep, unbiased proteomics across different human biofluids using the fully automated nanoparticle based Seer Proteograph™ Product Suite.

A Novel Approach for Deep Proteomic Insight Across Different Biofluids

Human body fluids provide a rich source of information that can be used to predict a patient’s disease state and guide drug development or personalized therapies.

In this webinar we show how the combination of the Proteograph Product Suite and high-end mass spectrometry provides unbiased access to thousands of proteins that have not been detectable by conventional proteomics techniques.

For the first time we present unique insight into Evotec’s benchmark data set on human serum, plasma, cerebrospinal fluid (CSF), urine and cell secretome. Learn more about Evotec's Clinical Proteomics offering here.

Meet Our Speakers

headshot of Carleen Kluger
Evotec logo big

Carleen Kluger

Group Leader of Clinical Proteomics at Evotec

Evotec logo big

Latest update: November 2024

Biography


Carleen Kluger, Group Leader of Clinical Proteomics at Evotec, has built a remarkable career at the intersection of (bio)physics and biology. Throughout her academic journey, she delved into complex biological processes, leveraging cutting-edge technologies such as molecular tension sensors and high-resolution imaging-based methods. Evolving from a bioinformatician to a leader in clinical proteomics, Carleen spearheaded the implementation of novel mass spectrometry-based approaches for biofluids and tissues from humans and animals.

In her role, Carleen collaborates closely with clients to develop innovative protein biomarkers that enhance the success of pre-clinical and clinical studies across diverse therapeutic areas, from neurodegeneration to oncology and rare diseases. Embracing a curiosity for exploring new frontiers, her team pioneers’ technologies like extracellular vesicle enrichment, nanoparticle-based proteomics, and multi-omics data integration.

Evotec logo big
headshot of Daniel Hornburg

Daniel Hornburg

VP, Proteomics at Seer

Latest update: November 2024

Biography


Vice President and scientific leader in precision omics, developing and integrating mass spec-based multi-omics solutions to characterize the proteome, metabolome as well as lipidome and dissect molecular big data with tailored machine-learning strategies. Daniel earned his PhD at the Max Planck Institute and graduated from the Technical University Munich with a Master of Science in Molecular Biotechnology.

Watch On-Demand Webinar

If the webinar has not loaded above, please follow the link here.